InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (22 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
22
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Glickman Sarah JS, Chief Financial Officer. Officer active across 4 companies, notably bluebird bio, Inc.. In total, 42 reports have been published. Split: 0 buy · 22 sells. Total volume traded: €3.2m. Activity tracked since 29 September 2021. The latest transaction was filed on 6 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Glickman Sarah JS
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations42 total
6,285 shares@ US$17.230.0096% mcap2.8% of flowOrdinary SharesSEC:0001749338-26-000017:0
430,897 shares0Ordinary SharesSEC:0001628280-26-050592:0
430,897 shares0Ordinary SharesSEC:0001628280-26-050592:1
151 shares0Common StockSEC:0000896622-26-000150:0
1,313 shares@ US$17.060.0025% mcap0.7% of flowOrdinary SharesSEC:0001749338-26-000013:0
1,152 shares@ US$17.060.0022% mcap0.7% of flowOrdinary SharesSEC:0001749338-26-000013:1
83,502 shares0Ordinary SharesSEC:0001749338-26-000008:0
18,304 shares@ US$17.999.2% of flowOrdinary SharesSEC:0001749338-26-000006:0
17,284 shares0Ordinary SharesSEC:0001749338-26-000004:0
2,796 shares@ US$16.811.3% of flowOrdinary SharesSEC:0001749338-26-000002:0
3,982 shares@ US$19.512.5% of flowOrdinary SharesSEC:0001749338-25-000005:0
3,981 shares@ US$24.063.1% of flowOrdinary SharesSEC:0001749338-25-000003:0
2,465 shares@ US$25.811.8% of flowOrdinary SharesSEC:0001576427-25-000074:0
1,520 shares@ US$26.121.1% of flowOrdinary SharesSEC:0001576427-25-000074:1
12,050 sharesCommon StockSEC:0001562180-25-003912:0
1,069 shares0Common StockSEC:0001062993-25-008959:0
38,724 shares0Ordinary SharesSEC:0001576427-25-000033:0
17,883 shares@ US$40.3026.8% of flowOrdinary SharesSEC:0001576427-25-000025:0
1,520 shares@ US$40.362.3% of flowOrdinary SharesSEC:0001576427-24-000146:0
5,442 shares@ US$40.608.0% of flowOrdinary SharesSEC:0001576427-24-000115:0
1,519 shares@ US$49.172.6% of flowOrdinary SharesSEC:0001576427-24-000108:0
5,496 shares@ US$45.498.9% of flowOrdinary SharesSEC:0001576427-24-000092:0
12,050 shares0Common StockSEC:0001562180-24-005008:0
1,535 shares@ US$38.992.1% of flowOrdinary SharesSEC:0001576427-24-000070:0
1,113 shares0Common StockSEC:0001062993-24-009225:0
25 of 42 declarations
About Glickman Sarah JS
Sarah JS Glickman is Chief Financial Officer and has 38 filings in total. Across the 38 recent filings tracked, all sales, the total sell amount is EUR 3135606, with filings dated from 2021-10-01 to 2026-05-28, mainly in Criteo S.A., and also in 2seventy bio, Inc., Aptargroup, INC. and bluebird bio, Inc.
